Paul W. Hoelscher

Insider Reports History

Entity
Individual
Location
1 Horizon Way, C/O Horizon Therapeutics, Inc., Deerfield, Illinois
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul W. Hoelscher:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Horizon Therapeutics Public Ltd Co EVP, CFO Ordinary Shares 72.8K $8.48M $116.50 Apr 20, 2022 By Trust
Horizon Therapeutics Public Ltd Co EVP, CFO Ordinary Shares 66.7K $7.77M $116.50 Apr 20, 2022 By LLC
Horizon Therapeutics Public Ltd Co EVP, CFO Ordinary Shares 1.05K $122K $116.50 Apr 20, 2022 Direct
Horizon Therapeutics Public Ltd Co EVP, CFO Stock Option (Right to Buy) 36.4K Apr 20, 2022 Direct
Reneo Pharmaceuticals, Inc. Director Stock Option (right to buy) 17.5K Jun 6, 2023 Direct
Sagimet Biosciences Inc. Director Stock Option (Right to Buy) 9.28K Jun 5, 2024 Direct

Insider Reports Filed by Paul W. Hoelscher

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGMT Sagimet Biosciences Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
SGMT Sagimet Biosciences Inc. Apr 1, 2024 1 $0 4 Apr 3, 2024 Director
SGMT Sagimet Biosciences Inc. Apr 1, 2024 0 $0 3 Apr 3, 2024 Director
RPHM Reneo Pharmaceuticals, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
RPHM Reneo Pharmaceuticals, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Director
HZNP Horizon Therapeutics Public Ltd Co Apr 20, 2022 4 -$4.63M 4 Apr 22, 2022 EVP, CFO
HZNP Horizon Therapeutics Public Ltd Co Apr 6, 2022 6 -$29.2M 4 Apr 8, 2022 EVP, CFO
HZNP Horizon Therapeutics Public Ltd Co Mar 23, 2022 10 -$3.98M 4 Mar 25, 2022 EVP, CFO
HZNP Horizon Therapeutics Public Ltd Co Jan 21, 2022 3 -$213K 4 Jan 24, 2022 EVP, CFO
RPHM Reneo Pharmaceuticals, Inc. Jan 20, 2022 1 $0 4 Jan 24, 2022 Director
RPHM Reneo Pharmaceuticals, Inc. Jan 20, 2022 0 $0 3 Jan 24, 2022 Director
HZNP Horizon Therapeutics Public Ltd Co Jan 4, 2022 9 -$5.16M 4 Jan 6, 2022 EVP, CFO
HZNP Horizon Therapeutics Public Ltd Co Dec 28, 2021 6 -$806K 4 Dec 30, 2021 EVP, CFO
HZNP Horizon Therapeutics Public Ltd Co Jul 28, 2021 3 -$395K 4 Jul 30, 2021 EVP, CFO
HZNP Horizon Therapeutics Public Ltd Co May 14, 2021 1 -$9.26M 4 May 14, 2021 EVP, CFO